BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16033073)

  • 21. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.
    Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N
    Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
    Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
    Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
    Brustmann H
    Pathol Res Pract; 2007; 203(2):65-72. PubMed ID: 17258405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical study of Ki-67 and DNA topoisomerase II in human endometrium.
    Ito K; Sasano H; Yabuki N; Matsunaga G; Sato S; Kikuchi A; Yajima A; Nagura H
    Mod Pathol; 1997 Apr; 10(4):289-94. PubMed ID: 9110289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
    Skovlund VR
    APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
    Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
    Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
    Pilka R; Domanski H; Hansson S; Eriksson P; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):641-50. PubMed ID: 15273280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BAG-1 expression in normal endometrium, endometrial hyperplasia and endometrial cancer.
    Song JY; Kim JW; Lee JK; Lee NW; Yeom BW; Kim SH; Lee KW
    Acta Obstet Gynecol Scand; 2008; 87(8):862-7. PubMed ID: 18704778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue.
    Mylonas I; Makovitzky J; Hoeing A; Richter DU; Vogl J; Schulze S; Jeschke U; Briese V; Friese K
    Acta Histochem; 2006; 108(1):1-11. PubMed ID: 16423381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium.
    Sonoda K; Kaku T; Hirakawa T; Kobayashi H; Amada S; Sakai K; Nakashima M; Watanabe T; Nakano H
    Gynecol Oncol; 2000 Dec; 79(3):424-9. PubMed ID: 11104614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium.
    Snijders MP; de Goeij AF; Koudstaal J; Thunnissen EB; de Haan J; Bosman FT
    J Pathol; 1992 Feb; 166(2):171-7. PubMed ID: 1560318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Kriegel S; Kupka MS; Friese K
    Anticancer Res; 2005; 25(3A):1679-86. PubMed ID: 16033082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue.
    Pan XY; Wang B; Che YC; Weng ZP; Dai HY; Peng W
    Int J Gynecol Cancer; 2007; 17(1):233-41. PubMed ID: 17291259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urocortin expression is downregulated in human endometrial carcinoma.
    Florio P; De Falco G; Leucci E; Torricelli M; Torres PB; Toti P; Dell'Anna A; Tiso E; Santopietro R; Leoncini L; Petraglia F
    J Endocrinol; 2006 Jul; 190(1):99-105. PubMed ID: 16837614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
    Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
    Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
    Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
    J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of retinoblastoma protein expression in endometrial hyperplasia.
    Brucka A; Bartczak P; Sporny S
    Pol J Pathol; 2007; 58(3):173-82. PubMed ID: 18074862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAG-1 expression in normal and neoplastic endometrium.
    Moriyama T; Littell RD; Debernardo R; Oliva E; Lynch MP; Rueda BR; Duska LR
    Gynecol Oncol; 2004 Aug; 94(2):289-95. PubMed ID: 15297164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial human chorionic gonadotropin is expressed and produced in human secretory endometrium during the normal menstrual cycle.
    Zimmermann G; Ackermann W; Alexander H
    Biol Reprod; 2009 May; 80(5):1053-65. PubMed ID: 19164178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
    Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
    Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.